Search

Your search keyword '"Korobelnik, Jean-Francois"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Korobelnik, Jean-Francois" Remove constraint Author: "Korobelnik, Jean-Francois"
274 results on '"Korobelnik, Jean-Francois"'

Search Results

1. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

4. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

5. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

6. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

9. Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study

10. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

11. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia

16. Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning

22. Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration: The EYE-RISK Consortium

23. Faricimab Treat-and-Extend for Diabetic Macular Edema

25. Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population

26. The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans: A Meta-analysis of Published and Unpublished Data

28. Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future

31. Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies

33. Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration

35. Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies

38. Increasing Prevalence of Myopia in Europe and the Impact of Education

39. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome

42. Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortium

43. Associations with intraocular pressure across Europe: The European Eye Epidemiology (E³) Consortium

46. Intravitreal Aflibercept for Diabetic Macular Edema

47. Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

48. Prevalence of refractive error in Europe: the European Eye Epidemiology (E³) Consortium

50. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies

Catalog

Books, media, physical & digital resources